FDA approves XERAVA ™ for treatment of complex intraabdominal infections
-
Last Update: 2020-06-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
intra-abdominal infection (IAI) is a common problem in the clinic, including a variety of disease processesDepending on the degree of infection, IAI is classified as simplicity or complexityDue to perforation or other damage to the gastrointestinal tract, complexity IAI (cIAI) extends beyond the source organ into the peritoneal space (the space between the two membranes that separate the organs in the abdominal cavity from the abdominal wall)recently, Tetraphase Pharmaceuticals announced that the U.SFDA(™ eravacycline) for the treatment of complex intra-abdominal infections (cIAI)in clinicaltrial(in which eravacycline is well tolerated and shows a high clinical cure rate in patients with cIAI)eravacycline was statistically uneffective compared to two widely used antibiotics, Erthaperanand and MeropinanXERAVA ™
XERAVA™ (injecting eravacycline) developed by Tetraphase is a new type of full-
synthetic(fluorocycline)Eravacycline shows effective activity against MDR pathogens for patients 18 years and olderIn order to reduce the development of drug-resistant bacteria and maintain eravacycline and other antimicrobialdrug (effective, eravacycline should only be used only to treat or prevent infections that have been proven or strongly suspected to be caused by susceptible bacteria
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
